BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35614973)

  • 21. Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers.
    Han DH; Joe KH; Na C; Lee YS
    Psychiatr Genet; 2008 Feb; 18(1):11-6. PubMed ID: 18197080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters.
    Kolanos R; Sakloth F; Jain AD; Partilla JS; Baumann MH; Glennon RA
    ACS Chem Neurosci; 2015 Oct; 6(10):1726-31. PubMed ID: 26217965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
    Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
    Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome.
    El-Kasaby A; Kasture A; Koban F; Hotka M; Asjad HMM; Kubista H; Freissmuth M; Sucic S
    Neuropharmacology; 2019 Dec; 161():107572. PubMed ID: 30885608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.
    Argyelán M; Szabó Z; Kanyó B; Tanács A; Kovács Z; Janka Z; Pávics L
    J Affect Disord; 2005 Dec; 89(1-3):115-23. PubMed ID: 16213028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
    Mortensen OV; Amara SG
    J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and Clinical Repercussions of GABA Transporter 1 Variants Gone Amiss: Links to Epilepsy and Developmental Spectrum Disorders.
    Fischer FP; Kasture AS; Hummel T; Sucic S
    Front Mol Biosci; 2022; 9():834498. PubMed ID: 35295842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.
    Bulling S; Schicker K; Zhang YW; Steinkellner T; Stockner T; Gruber CW; Boehm S; Freissmuth M; Rudnick G; Sitte HH; Sandtner W
    J Biol Chem; 2012 May; 287(22):18524-34. PubMed ID: 22451652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bupropion occupancy of the dopamine transporter is low during clinical treatment.
    Meyer JH; Goulding VS; Wilson AA; Hussey D; Christensen BK; Houle S
    Psychopharmacology (Berl); 2002 Aug; 163(1):102-5. PubMed ID: 12185406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-dioxin-like PCBs inhibit [(3)H]WIN-35,428 binding to the dopamine transporter: a structure-activity relationship study.
    Wigestrand MB; Stenberg M; Walaas SI; Fonnum F; Andersson PL
    Neurotoxicology; 2013 Dec; 39():18-24. PubMed ID: 23933243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers.
    Bhat S; Newman AH; Freissmuth M
    Biochem Soc Trans; 2019 Jun; 47(3):861-874. PubMed ID: 31064865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors.
    Sershen H; Hashim A; Lajtha A
    Brain Res Bull; 1997; 42(3):161-8. PubMed ID: 8995326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB; Lopez MC; Tanaka JC
    Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
    Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism.
    Honkanen EA; Kemppainen N; Noponen T; Seppänen M; Joutsa J; Kaasinen V
    Clin Neuropharmacol; 2019; 42(5):181-183. PubMed ID: 31361666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography.
    Learned-Coughlin SM; Bergström M; Savitcheva I; Ascher J; Schmith VD; Långstrom B
    Biol Psychiatry; 2003 Oct; 54(8):800-5. PubMed ID: 14550679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label.
    Dutta AK; Fei XS; Vaughan RA; Gaffaney JD; Wang N; Lever JR; Reith ME
    Life Sci; 2001 Mar; 68(16):1839-49. PubMed ID: 11292062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions.
    Uhl GR; Lin Z
    Eur J Pharmacol; 2003 Oct; 479(1-3):71-82. PubMed ID: 14612139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.